Filer Snapshot

Matthew Malenfant

CIK 0001812287. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Individual

Total filings

11

Latest filing

13 Oct 2022

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: Forms 3/4/5 owner position for CVET. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Forms 3/4/5

4 filed on 13 Oct 2022 for CIK 0001812287.

View source filing
Business address
7 Custom House Street, Portland, ME, 04101

Filer intelligence

What SEC filings say about Matthew Malenfant

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Forms 3/4/5 show insider context for CVET.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 1 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

CVET

13 Oct 2022 ยท Chief Commercial Officer

Latest update

What changed recently for Matthew Malenfant

Ownership report updated

Latest ownership report period: 13 Oct 2022. Open the source-backed page to inspect the fresh filing or facts context.

Update date

13 Oct 2022

Page type

Ownership filings

Latest period

13 Oct 2022

Ownership context was refreshed from SEC Forms 3/4/5 filed on 13 Oct 2022.

SEC filing record

CIK 0001812287 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
11
First seen
20 May 2020
Latest filing
13 Oct 2022
Entity
Individual

Observed form types

4 3

Latest Filings

Showing the latest 11 of 11 SEC filings for Matthew Malenfant.

4 File 001-38794

FORM 4

Filing date
13 Oct 2022
Reporting date
13 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38794

FORM 4

Filing date
06 Sep 2022
Reporting date
01 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38794

FORM 4

Filing date
03 Jun 2022
Reporting date
01 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38794

FORM 4

Filing date
20 May 2022
Reporting date
18 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38794

FORM 4

Filing date
03 Mar 2022
Reporting date
01 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38794

FORM 4 SUBMISSION

Filing date
03 Sep 2021
Reporting date
01 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38794

FORM 4

Filing date
20 May 2021
Reporting date
18 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38794

FORM 4

Filing date
20 May 2021
Reporting date
14 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38794

FORM 4

Filing date
03 Mar 2021
Reporting date
01 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-38794

FORM 4

Filing date
20 May 2020
Reporting date
18 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-38794

FORM 3

Filing date
20 May 2020
Reporting date
18 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .